Elle this year arguably saved the best for last. Both the print and online layouts for the magazine’s August issue highlighting of tech-industry female superstars, sub-headlined “Star Tech Voyagers,” closes with Piraye Yurttas Beim, founder and CEO of New York biotech company Celmatix.
For starters, the company’s new blood test Fertilome, a multi-gene test that outlines a woman’s reproductive health, was released in January. Another Celmatix product, the software program Polaris, relies on the largest clinical data-set of fertility treatment outcomes.
Then there is the relevance of the company’s mandate to its progenitor:
At 32, just married and in the midst of getting Celmatix off the ground, Beim was diagnosed with diminished ovarian reserves.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in